View Future GrowthDNFLtd 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 DNFLtd 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Semiconductor 산업 성장률23.50%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2023최근 과거 실적 업데이트Reported Earnings • Mar 26Full year 2022 earnings released: EPS: ₩499 (vs ₩1,083 in FY 2021)Full year 2022 results: EPS: ₩499 (down from ₩1,083 in FY 2021). Revenue: ₩135.2b (up 6.4% from FY 2021). Net income: ₩5.77b (down 52% from FY 2021). Profit margin: 4.3% (down from 9.4% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.모든 업데이트 보기Recent updates공시 • Mar 13DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: dream hall, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea공시 • Feb 06DNF Co.,Ltd. announces Annual dividendDNF Co.,Ltd. announced Annual dividend of KRW 100.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.New Risk • Dec 16New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩144.6b (US$98.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Market cap is less than US$100m (₩144.6b market cap, or US$98.0m).New Risk • Aug 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).공시 • May 21DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares.DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co., Ltd. The purpose of the program is to enhance shareholder value and to stabilize stock price. The program will be valid until November 19, 2025. As of May 19, 2025, the company had 187,780 shares in treasury under the dividend capacity and no shares in treasury under other capacities.New Risk • Mar 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₩111.4b market cap, or US$76.9m).공시 • Mar 12DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea공시 • Dec 20DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares.DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co.Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until June 19, 2025. As of December 19, 2024, the company had 0 shares in treasury under the dividend capacity and no shares in treasury under other capacities.Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 15 April 2025. Trailing yield: 2.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (0.8%).New Risk • Nov 14New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risk Market cap is less than US$100m (₩111.4b market cap, or US$79.3m).New Risk • Sep 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.6b (US$98.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩132.6b market cap, or US$98.9m).New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).분석 기사 • Mar 26Getting In Cheap On DNF Co.,Ltd. (KOSDAQ:092070) Is UnlikelyDNF Co.,Ltd.'s ( KOSDAQ:092070 ) price-to-sales (or "P/S") ratio of 2.5x may not look like an appealing investment...Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per share at 0.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 12 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).New Risk • Aug 26New major risk - Revenue and earnings growthEarnings have declined by 5.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.2% net profit margin).Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩20,850, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩24,300, the stock trades at a trailing P/E ratio of 41.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 58% over the past three years.Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩20,200, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩17,750, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.Reported Earnings • Mar 26Full year 2022 earnings released: EPS: ₩499 (vs ₩1,083 in FY 2021)Full year 2022 results: EPS: ₩499 (down from ₩1,083 in FY 2021). Revenue: ₩135.2b (up 6.4% from FY 2021). Net income: ₩5.77b (down 52% from FY 2021). Profit margin: 4.3% (down from 9.4% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Dec 21Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 30 April 2023. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩16,800, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 144% over the past three years.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Upcoming Dividend • Dec 22Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 30 April 2022. Payout ratio is a comfortable 23% but the company is paying out more than the cash it is generating. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).Valuation Update With 7 Day Price Move • Nov 30Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩18,150, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.공시 • Aug 12DNF Co.,Ltd. announced that it has received KRW 20.9635764 billion in funding from Samsung Electronics Co., Ltd.On August 11, 2021, DNF Co.,Ltd. closed the transaction.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩28,250, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 151% over the past three years.Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩26,000, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 123% over the past three years.분석 기사 • Apr 14We Think DNFLtd (KOSDAQ:092070) Can Manage Its Debt With EaseSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Mar 24Should You Be Adding DNFLtd (KOSDAQ:092070) To Your Watchlist Today?It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...Is New 90 Day High Low • Feb 09New 90-day high: ₩27,150The company is up 96% from its price of ₩13,850 on 11 November 2020. The South Korean market is up 24% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period.Is New 90 Day High Low • Jan 13New 90-day high: ₩23,250The company is up 69% from its price of ₩13,750 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,150, the stock is trading at a trailing P/E ratio of 26.3x, up from the previous P/E ratio of 22.3x. This compares to an average P/E of 15x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 54%.Is New 90 Day High Low • Dec 17New 90-day high: ₩17,150The company is up 20% from its price of ₩14,250 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 20% over the same period.분석 기사 • Dec 14DNFLtd (KOSDAQ:092070) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Is New 90 Day High Low • Dec 02New 90-day high: ₩16,550The company is up 18% from its price of ₩14,050 on 03 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to ₩15,200, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 16.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total return to shareholders over the past three years is a loss of 4.0%.Is New 90 Day High Low • Oct 26New 90-day low: ₩12,100The company is down 24% from its price of ₩15,850 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.공시 • Jun 19DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion.DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion on June 15, 2020. Under the terms, 0.8 million shares will be acquired at a ratio of 0.730025 as a part of the acquisition. Post the completion of the transaction DNF will hold 50.19% stake in ChemOptics and will operate as a subsidiary of DNF. ChemOptics reported total assets of KRW 22.7 billion, sales of KRW 22.4 billion and net loss of KRW 1.3 billion. The transaction is expected to close on July 1, 2020.매출 및 비용 세부 내역DNFLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A092070 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비30 Sep 23106,535-2,70412,7119,00630 Jun 23121,1982,68012,9628,45831 Mar 23130,8556,72813,1037,85031 Dec 22135,1795,77412,3017,44430 Sep 22141,20217,04012,8167,66330 Jun 22140,06814,97412,5048,10231 Mar 22134,45013,22212,1128,73231 Dec 21127,05612,00611,6479,39530 Sep 21119,9149,46411,5689,36630 Jun 21113,18513,25711,0739,51231 Mar 21104,64016,39610,3168,70631 Dec 2095,09815,0209,4428,19430 Sep 2081,65811,1428,1377,72331 Dec 1958,8152,2317,4527,014양질의 수익: A092070가 고품질 수익을 갖고 있는지 판단하기에는 데이터가 부족합니다.이익 마진 증가: 지난 1년 동안 A092070의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 A092070의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: A092070의 지난해 수익 성장률을 5년 평균과 비교하기에 데이터가 부족합니다.수익 대 산업: A092070의 지난 해 수익 증가율이 Semiconductor 업계 평균을 상회했는지 판단하기에 데이터가 부족합니다.자기자본이익률높은 ROE: A092070는 현재 수익성이 없으므로 자본 수익률이 음수(0%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSemiconductors 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/23 20:59종가2026/05/22 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스DNF Co.,Ltd.는 6명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Sang Uk KimBarclaysKyung Min KimDaishin Securities Co. Ltd.Jeong LeeEugene Investment & Securities Co Ltd.3명의 분석가 더 보기
Reported Earnings • Mar 26Full year 2022 earnings released: EPS: ₩499 (vs ₩1,083 in FY 2021)Full year 2022 results: EPS: ₩499 (down from ₩1,083 in FY 2021). Revenue: ₩135.2b (up 6.4% from FY 2021). Net income: ₩5.77b (down 52% from FY 2021). Profit margin: 4.3% (down from 9.4% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Mar 13DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: dream hall, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea
공시 • Feb 06DNF Co.,Ltd. announces Annual dividendDNF Co.,Ltd. announced Annual dividend of KRW 100.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.
New Risk • Dec 16New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩144.6b (US$98.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Market cap is less than US$100m (₩144.6b market cap, or US$98.0m).
New Risk • Aug 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
공시 • May 21DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares.DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co., Ltd. The purpose of the program is to enhance shareholder value and to stabilize stock price. The program will be valid until November 19, 2025. As of May 19, 2025, the company had 187,780 shares in treasury under the dividend capacity and no shares in treasury under other capacities.
New Risk • Mar 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₩111.4b market cap, or US$76.9m).
공시 • Mar 12DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea
공시 • Dec 20DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares.DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co.Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until June 19, 2025. As of December 19, 2024, the company had 0 shares in treasury under the dividend capacity and no shares in treasury under other capacities.
Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 15 April 2025. Trailing yield: 2.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (0.8%).
New Risk • Nov 14New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risk Market cap is less than US$100m (₩111.4b market cap, or US$79.3m).
New Risk • Sep 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.6b (US$98.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩132.6b market cap, or US$98.9m).
New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
분석 기사 • Mar 26Getting In Cheap On DNF Co.,Ltd. (KOSDAQ:092070) Is UnlikelyDNF Co.,Ltd.'s ( KOSDAQ:092070 ) price-to-sales (or "P/S") ratio of 2.5x may not look like an appealing investment...
Upcoming Dividend • Dec 20Upcoming dividend of ₩200 per share at 0.9% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 12 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
New Risk • Aug 26New major risk - Revenue and earnings growthEarnings have declined by 5.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.2% net profit margin).
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩20,850, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩24,300, the stock trades at a trailing P/E ratio of 41.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 58% over the past three years.
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩20,200, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩17,750, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.
Reported Earnings • Mar 26Full year 2022 earnings released: EPS: ₩499 (vs ₩1,083 in FY 2021)Full year 2022 results: EPS: ₩499 (down from ₩1,083 in FY 2021). Revenue: ₩135.2b (up 6.4% from FY 2021). Net income: ₩5.77b (down 52% from FY 2021). Profit margin: 4.3% (down from 9.4% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Dec 21Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 30 April 2023. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩16,800, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 144% over the past three years.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Upcoming Dividend • Dec 22Upcoming dividend of ₩200 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 30 April 2022. Payout ratio is a comfortable 23% but the company is paying out more than the cash it is generating. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩18,150, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.
공시 • Aug 12DNF Co.,Ltd. announced that it has received KRW 20.9635764 billion in funding from Samsung Electronics Co., Ltd.On August 11, 2021, DNF Co.,Ltd. closed the transaction.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩28,250, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 151% over the past three years.
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩26,000, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 123% over the past three years.
분석 기사 • Apr 14We Think DNFLtd (KOSDAQ:092070) Can Manage Its Debt With EaseSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Mar 24Should You Be Adding DNFLtd (KOSDAQ:092070) To Your Watchlist Today?It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Is New 90 Day High Low • Feb 09New 90-day high: ₩27,150The company is up 96% from its price of ₩13,850 on 11 November 2020. The South Korean market is up 24% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period.
Is New 90 Day High Low • Jan 13New 90-day high: ₩23,250The company is up 69% from its price of ₩13,750 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,150, the stock is trading at a trailing P/E ratio of 26.3x, up from the previous P/E ratio of 22.3x. This compares to an average P/E of 15x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 54%.
Is New 90 Day High Low • Dec 17New 90-day high: ₩17,150The company is up 20% from its price of ₩14,250 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 20% over the same period.
분석 기사 • Dec 14DNFLtd (KOSDAQ:092070) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Is New 90 Day High Low • Dec 02New 90-day high: ₩16,550The company is up 18% from its price of ₩14,050 on 03 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.
Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to ₩15,200, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 16.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total return to shareholders over the past three years is a loss of 4.0%.
Is New 90 Day High Low • Oct 26New 90-day low: ₩12,100The company is down 24% from its price of ₩15,850 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
공시 • Jun 19DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion.DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion on June 15, 2020. Under the terms, 0.8 million shares will be acquired at a ratio of 0.730025 as a part of the acquisition. Post the completion of the transaction DNF will hold 50.19% stake in ChemOptics and will operate as a subsidiary of DNF. ChemOptics reported total assets of KRW 22.7 billion, sales of KRW 22.4 billion and net loss of KRW 1.3 billion. The transaction is expected to close on July 1, 2020.